Suzuki H, Kakizaki S, Horiguchi N, Ichikawa T, Sato K, Takagi H, Mori M. Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C. World J Hepatol 2010; 2(11): 401-405 [PMID: 21173908 DOI: 10.4254/wjh.v2.i11.401]
Corresponding Author of This Article
Satoru Kakizaki, MD, PhD, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan. kakizaki@showa.gunma-u.ac.jp
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/